Abstract
The last few years have seen a marked increase in the research on the biochemical and pharmacological consequences of repeated electroconvulsive shock (ECS), for several reasons. The first reason is that electroconvulsive therapy (ECT) is still acknowledged as the most successful treatment for severe depressive illness (see Brandon et al., 1984: Royal College of Psychiatrists, 1977; Fink, 1979). The second reason is that greater insight has now been gained into the mechanism of action of antidepressant drugs, so it seems reasonable to determine whether the experimental effects of ECS are similar to those of the drugs. The third reason is that ECT remains a controversial treatment, and thus a greater understanding of its mechanism of action may eventually lead to the development of a pharmacological agent with the efficacy of ECT but, it is to be hoped, fewer side effects and less public disquiet.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams, H. E., Hoblit, P. R., and Sulker, P. D., 1969, Electroconvulsive shock, brain acetylcholinesterase activity and memory, Physiol. Behav. 4: 113–116.
Appleyard, M. E., Green, A. R., and Smith, A. D., 1984, Regional acetylcholinesterase activity in rat brain following a convulsion, Br. J. Pharmacol. 82: 248 P.
Appleyard, M. E., Green, A. R., and Smith, A. D., 1985, Acetylcholinesterase activity in regions of the rat brain following a convulsion, J. Neurochem. 46: 1789–1793.
Atterwill, C. K., 1980, Lack of effect of repeated electroconvulsive shock on [3H]-5-hydroxytryptamine binding and cholinergic parameters in rat brain, J. Neurochem. 35: 729–734.
Atterwill, C. K., 1984, The effects of ECS on central cholinergic and interrelated neurotransmitter systems, in: ECT: Basic Mechanisms ( B. Lerer, R. D. Weiner, and R. H. Belmaker, eds.), John Libbey Co., London, pp. 79–88.
Atterwill, C. K., and Green, A. R., 1980, Responses of developing rats to L-tryptophan plus an MAOI. II: Effects of repeated electroconvulsive shock, Neuropharmacology 19: 337–341.
Atterwill, C. K., Batts, C., and Bloomfield, M. R., 1981, Effect of single and repeated convulsions on glutamate decarboyxlase (GAD) activity and [3H]-muscimol binding in the rat brain, J. Pharm. Pharmacol. 33: 329–331.
Atweh, S., Simon, J. R., and Kuhar, J. J., 1976 Utilisation of sodium-dependent high affinity choline uptake in vitro as a measure of the activity of cholinergic neurons in vivo, Life Sci. 17: 1535–1544.
Balldin, J., Granerus, A. K., Lindstedt, G., Modigh, K., and Walinder, J., 1982, Neuroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy, Psychopharmacology 76: 371–376.
Belenky, G. L., and Holaday, J. W., 1979, The opiate antagonist naloxone modifies the effect of electroconvulsive shock (ECS) on respiration, blood pressure and heart rate, Brain Res. 117: 414–417.
Belenky, G. L., and Holaday, J. W., 1981, Repeated electroconvulsive shock (ECS) and morphine tolerance: Demonstration of cross-sensitivity in the rat, Life Sci. 29: 553–563.
Belenky, G. L., Tortella, F. C., Hitzemann, R. J., and Holaday, J. W., 1984, The role of endorphine systems in the effects of ECS, in: ECT: Basic Mechanisms ( B. Lerer, R. D. Weiner, and R. H. Belmaker, eds.), John Libbey Co., London, pp. 89–97.
Belmaker, R. H., Lerer, B., Bannet, J., and Birmaher, B., 1982, The effect of electroconvulsive shock at a clinically equivalent schedule on rat cortical β-adrenoceptors, J. Pharm. Pharmacol. 34: 275.
Bergström, D. A., and Kellar, K. J., 1979, Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain, Nature 278: 464–466.
Bertilsson, L., and Costa, E., 1976, Mass-fragmentographic quantification of glutamic acid and ϒ-aminobutyric acid in cerebellar nuclei and sympathetic ganglia of rats, J. Chromatogr. 118: 395–402.
Bhavsar, V. H., Dhumal, V. R., and Kelkar, V. V., 1981, The effect of some anti-epilepsy drugs on enhancement of the monoamine-mediated behavioural responses following the administration of electroconvulsive shocks to rats, Eur. J. Pharmacol. 74: 243–247.
Bowdler, J. M., and Green, A. R., 1982, Regional rat brain benzodiazepine receptor number and ϒ-aminobutyric acid concentration following a convulsion, Br. J. Pharmacol. 76: 291–298.
Bowdler, J. M., Green, A. R., and Rawle, F. C., 1980, Brain and serum calcium concentrations following electroconvulsive shock or bicuculline-induced convulsions in rats, Br. J. Pharmacol. 71: 321–325.
Bowdler, J. M., Green, A. R., Minchin, M. C. W., and Nutt, D. J., 1983, Regional GABA concentrations and [3H]-diazepam binding in rat brain following repeated electroconvulsive shock, J. Neural Transm. 56: 3–12.
Bowery, N.G., Hill, D.R., Hudson, A.L., Doble, A., Middlemiss, D.N., Shaw, J., and Turnbull, M., 1980, (-)-Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor, Nature 283: 92–94
Brandon, S., Cowley, P., Mcdonald, C., Neville, P., Palmer, R., and Wellstood-Eason, S., 1984, Electroconvulsive therapy: Results in depressive illness from the Leicestershire trial, Br. Med. J. 188: 22–25.
Brunello, N., Barbaccia, M. L., Chuang, D. M., and Costa, E., 1982, Down-regulation of β-adrenergic receptors following repeated injections of desmethylimipramine: Permissive role of serotonergic axons, Neuropharmacology 21: 1145–1149.
Carman, J. S., and Wyatt, R. J., 1977, Alterations in cerebrospinal fluid and serum total calcium with changes in psychiatric state, in: Neuroregulators and Psychiatric Disorders ( E. Usdin, D. Hamburg, and J. Barchas, eds.), Oxford University Press, New York, pp. 488–494.
Carman, J. S., Post, R. M., Goodwin, F. K., and Bunney, W. E., 1977, Calcium and electroconvulsive therapy of severe depressive illness, Biol. Psychiatry 12: 5–17.
Chapman, A. G., 1981, Free fatty acid release and metabolism of adenosine and cyclic nucleotides during prolonged seizures, in: Neurotransmitters, Seizures and Epilepsy ( P. L. Morselli, P. G. Lloyd, W. Löscher, B. Meldrum, and E. H. Reynolds, eds.) Raven Press, New York, pp. 165–173.
Checkley, S. A., Slade, A. P., and Shur, E., 1981, Growth hormone and other response to clonidine in patients with endogenous depression, Br. J. Psychiatry 138: 51–55.
Checkley, S. A., Meldrum, B. S., and Mcwilliam. J. R., 1984. Mechanisms of action of ECT: Neuroendocrine studies, in: ECT: Basic Mechanisms (B. Lerer, R. D. Weiner, and R. H. Belmaker, eds.), John Libbey 8c Co., London, pp. 101–106.
Chiodo, L. A., and Antelman, S. M., 1980, Electroconvulsive shock: progressive dopamine autoreceptor subsensitivity independent of repeated treatment, Science 210: 799–801.
Christie, J. E., Whalley, L. J., Brown, N. S., et al, 1982, Effect of ECT on the neuroendocrine response to apomorphine in severely depressed patients, Br. J. Psychiatry 140: 268–273.
Costa, E., 1979, The role of gamma-amino butyric acid in the action of 1, 4-benzodiazepines, Trends Pharm. Sci. 1: 41–45.
Costa, E., and Barbaccia, M. L., 1984, Regulation of 5-hydroxy-tryptamine (5-HT) uptake: Endocoid modulators and the action of imipramine, in: Proceedings of the 9th International Congress of Pharmacology, Vol. 3 ( W.D.M. Paton, J. F. Mitchell, and P. Turner, eds.), Macmillan Press, Basingstoke, England, pp. 109–116.
Costain, D. W., Green, A. R., and Grahame-Smith, D. G., 1979, Enhanced 5-hydroxytryptamine-mediated behavioural responses in rats following repeated electroconvulsive shock: Relevance to the mechanism of the antidepressive effect of electroconvulsive therapy, Psychopharmacology 61: 167–170.
Costain, D. W., Cowen, P. J., Gelder, M. G., and Grahame-Smith, D. G., 1982, Electroconvulsive therapy and the brain: Evidence for increased dopamine-mediated responses, Lancet 2: 360–362.
Costall, B., and Olley, J. E., 1971, Cholinergic and neuroleptic-induced catalepsy: Modification by lesions in the caudate putamen, Neuropharmacology 10: 297–306.
Cowen, P. J., 1985, Neuroendocrine responses as a probe into the mechanisms of action of ECT, Ann. NY Acad. Sci. 462: 163–171.
Cowen, P. J., and Nutt, D. J., 1982, Repeated electroconvulsive shock enhances the anticonvulsant effect of benzodiazepines, Br. J. Pharmacol 75: 44 P.
Cowen, P. J., Nutt, D. J., Baits, C. C., Green, A. R., and Heal, D. J., 1982, Repeated administration of subconvulsant doses of GABA antagonist drugs. II: Effect on mono-amine-mediated behaviour, Psychopharmacology 76: 88–91.
Creese, I., Kuczenski, R., and Segal, D., 1982, Lack of behavioural evidence for dopamine autoreceptor subsensitivity after acute electroconvulsive shock, Pharmacol Biochem. Behav. 17: 375–376.
Cupello, A., Fermillo, F., and Rozadini, G., 1981, Long lasting effects of electroconvulsive shock on the pattern of poly(A)-RNA synthesis in rabbit cerebral cortex, Neurochem. Res. 6: 175–182.
Dashieff, R. M., Savage, D. D., and Mcnamara, J. O., 1982, Seizures down-regulate muscarinic cholinergic receptors in hippocampal formation, Brain Res. 235: 327–334.
Davies, C. L., and Nutt, D. J., 1983, Repeated electroconvulsive shock alters diazepam pharmacokinetics in rats, Br. J. Pharmacol. 78: 114 P.
Davies, J. A., and Williams, J., 1978, The effect of baclofen on α-flupenthixol-induced catalepsy in the rat, Br. J. Pharmacol. 62: 303–305.
Deakin, J. F. W., Owen, F., Cross, A. J., and Dashwood, M. J., 1981, Studies on possible mechanisms of action of electroconvulsive therapy: Effects of repeated electrically- induced seizures on rat brain receptors for monoamines and other neurotransmitters, Psychopharmacology 73: 345–349.
de Montigny, C., 1984, Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin, J. Pharmacol. Exp. Ther. 228: 230–236.
Dismukes, R. K., and Daly, J. W., 1974, Norepinephrine-sensitive systems generating adenosine 3′5′-monophosphate: Increased responses in cerebral cortical slices from reserpine-treated rats, Mol. Pharmacol. 10: 933–940.
Durant, C. J., Duncan, N. A. M., Gannelin, C. R., Parsons, M. E., Blakemore, R., and Rasmussen, A., 1978, Impromidine (SK&F-92676) is a very potent and specific agonist for histamine H2 receptors, Nature 276: 403–405.
Emrich, H. M., and Höllt, V., 1984, Effect of ECT on endorphinergic systems: Clinical aspects, in: ECT: Basic Mechanisms ( B. Lerer, R. D. Weiner, and R. H. Belmaker, eds.), John Libbey Co., London, pp. 98–100.
Essman, W. B., 1974, Neurochemistry of Cerebral Electroshock, John Wiley, New York.
Evans, J. P. M., Grahame-Smith, D. G., Green, A. R., and Tordoff, A. F. C., 1976, Electroconvulsive shock increases the behavioural response of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs, Br. J. Pharmacol. 56: 193–199.
Faragalla, F. F., and Flach, F., 1970, Studies of mineral metabolism in mental depression. I. The effects of imipramine and electric convulsive therapy on calcium balance and kinetics J. Nero. Ment. Dis. 151: 120–129.
Feighner, J. P., Low, L., King, L. J., and Ross, W. J., 1972, Brain serotonin and norepinephrine after convulsions and reserpine, J. Neurochem. 19: 905–907.
Ferendelli, J. A., and Kinscherf, D. A., 1977, Cyclic nucleotides in epileptic brain: Effects of pentylenetetrazol on regional cyclic AMP and cyclic GMP in vivo, Epilepsia 18: 525–531.
File, S. E., 1980, The use of social interaction as a method of detecting anxiolytic activity of chlordiazepoxide-like drugs, J. Neurosci. Methods 2: 219–238.
File, S. E., and Green, A. R., 1984, Repeated electroconvulsive shock has no specific anxiolytic effect but reduces social interaction and exploration in rats, Neuropharmacology 23: 95–99.
Fink, M., 1974, Induced seizures and human behaviour, in: Psychobiology of Convulsive Therapy (M. Fink, S. Kety, J. McGaugh, and T. A. Williams, eds.), V. H. Winston 8c Sons, Washington, DC, pp. 1–17.
Fink, M., 1979, Convulsive Therapy: Theory and Practice, Raven Press, New York.
Fink, M., 1984, Theories of convulsive therapy: a neuroendocrine hypothesis, in: ECT Basic Mechanisms ( B. Lerer, R. D. Weiner, and R. H. Belmaker, eds.), John Libbey Co., London, pp. 115–123.
Fink, M., and Ottosson, J.-O., 1980, A theory of convulsive therapy in endogenous depression: Significance of hypothalamic functions, Psychiatr. Res. 2: 49–61.
Flach, F. F., 1964, Calcium metabolism in states of depression, Br. J. Psychiatry 110: 588–593.
Flach, F. F., Liang, E., and Stokes, P. E., 1960, Effects of electric convulsive treatments on nitrogen, calcium and phosphorous metabolism in psychiatric patients, J. Ment. Sci. 106: 638–647.
Freeman, C. P. L., Basson, J. V., and Crichton, A., 1978, Double-blind controlled trial of electroconvulsive therapy (ECT) and simulated ECT in depressive illness, Lancet 1: 738–740.
Frenk, H. J., Engel, J., Ackerman, R. F., Shavit, Y., and Liebeskind, J. C., 1979, Endogenous opiates may mediate post-ictal behavioural depression in amygdaloid-kindled rats, Brain Res. 167: 435–440.
Frith, C. D., Stevens, M., Johnstone, E. C., Deakin, J. F. W., Lawler, P., and Crow, T. J., 1983, Effects of ECT and depression on varous aspects of memory, Br. J. Psychiatry 142: 610–617.
Gandolfi, O., Dall’olio, R., and Montanaro, N., 1978, Early changes in rat brain 5-HT synthesis after a single electro-convulsive shock, Pharmacol. Res. Commun. 10: 75–79.
Garcia, A., Wang, C. H., Salama, A. I., and U’prichard, D.C., 1982, Regulation of rat cerebral cortex α2-receptor affinity states after electroconvulsive shock and antidepressant treatment, Soc. Neurosci. Abstr. 8: 525
Gilbert, R. F. T., Emson, P. C., Hunt, S., Bennett, G. W., Marsden, C. A., Sandberg, B. E. B., and Steinbusch, H. W., 1981, The effect of monoamine neurotoxins on peptides in the rat spinal cord, Neuroscience 7: 69–87.
Gillespie, D. D., Manier, D. H., and Sulser, F., 1979, ECT: Rapid subsensitivity of NA adenylate cyclase system in brain linked to down regulation of beta-receptors, Commun. Psychopharmacology 3: 191–195.
Globus, M., Lerer, B., Hamburger, R., and Belmaker, R., 1981, Chronic electroconvulsive shock and chronic haloperidol are not additive in effects on dopamine receptors, Neuropharmacology 20: 1125–1128.
Goodwin, G. M., and Green, A. R., 1985, A behavioural and biochemical study in mice and rats of putative agonists and antagonists for 5-HT1 and 5-HT2 receptors, Br. J. Pharamacol. 84: 743–753.
Goodwin, G. M., and Heal, D. J., 1985, DSP-4 lesioning abolishes the enhanced mono-amine-mediated behaviour following repeated electroconvulsive shock, Br. J. Pharmacol. 84: 538.
Gour, K. N., and Chaudhry, H. M., 1957, Study of calcium metabolism in electric convulsive therapy (ECT) in certain mental diseases, J. Ment. Sci. 103: 275–285.
Grahame-Smith, D. G., Green, A. R., and Costain, D. W., 1978, Mechanism of the antidepressant action of electroconvulsive therapy, Lancet 1: 254–256.
Gray, J. A., Metz, A., Goodwin, G. M., and Green, A. R., 1986, The effects of the GABA-mimetic drugs Progabide and Baclefen on the biochemistry and function of 5-hydroxy-tryptamine and noradrenaline, Neuropharmacology 25: 711–716.
Green, A. R., 1978, Repeated exposure of rats to the convulsant agent flurothyl enhanced 5-hydroxytryptamine-and dopamine-mediated behavioural responses, Br. J. Pharmacol. 62: 325–331.
Green, A.R., 1986a, Changes in GABA biochemistry and seizure threshold, Ann. NY Acad. Sci. 462: 105–119
Green, A.R., 1986b, Electroconvulsive therapy: A GABAergic mechanism? in: GABA and Mood Disorders: Animal and Clinical Studies (K.G. Lloyd, G. Bartholini, and P.L. Morselli, eds.), Raven Press, New York, pp. 51–60
Green, A. R., and Deakin, J. F. W., 1980, Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour, Nature 285: 232–233.
Green, A. R., and Mountford, J. A., 1985, Diazepam administration to mice prevents some of the changes in monoamine-mediated behaviour produced by repeated electroconvulsive shock treatment, Psychopharmacology 86: 190–193.
Green, A. R., and Nutt, D. J., 1983, Antidepressants, in: Psychopharmacology, Vol. I ( D. G. Grahame-Smith and P.J. Cowen, eds.), Elsevier/Excerpta Medica, Amsterdam, pp. 1–37.
Green„A. R., and Nutt, D. J., 1985, Antidepressants, in: Psychopharmacology, Vol. II ( D. G. Grahame-Smith and P. J. Cowen, eds.), Elsevier/Excerpta Medica, Amsterdam, pp. 1–33.
Green, A. R., Tordoff, A. F. C., and Bloomfield, M. R., 1976, Elevation of brain GABA concentrations with amino-oxyacetic acid: Effect on the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats, J. Neural Transm. 39: 103–112.
Green, A. R., Heal, D. J., and Grahame-Smith, D. C., 1977, Further observations on the effect of repeated electroconvulsive shock on the behavioural responses of rats produced by increases in the functional activity of brain 5-hydroxytryptamine and dopamine, Psychopharmacology 52: 195–200.
Green, A. R., Peralta, E., Hong, J. S., Mao, C. D., Atterwill, C. K., and Costa, E., 1978, Alterations in GABA metabolism and met-enkephalin content in rat brain following repeated electroconvulsive shocks, J. Neurochem. 31: 607–611.
Green, A. R., Bloomfield, M. R., Atterwill, C. K., and Costain, D. W., 1979, Electroconvulsive shock recuces the cataleptogenic effects of both haloperidol and arecoline in rats, Neuropharmacology 18: 447–451.
Green, A. R., Costain, D. W., and Deakin, J. F. W., 1980, Enhanced 5-hydroxytryptamine-and dopamine-mediated behavioural response following convulsions. Ill: The effects of monoamine antagonists and synthesis inhibitors on the ability of electroconvulsive shock to enhance responses, Neuropharmacology 19: 907–914.
Green, A. R., Sant, K., Bowdler, J. M., and Cowen, P. J., 1982, Further evidence for a relationship between changes in GABA concentrations in rat brain and enhanced monoamine-mediated behaviours following repeated electroconvulsive shock, Neuropharmacology 21: 981–984.
Green, A.R., Heal, D.J., Johnson, P., Laurence, B.E., and Nimgaonkar, V.L., 1983a, Antidepressant treatments: effects in rodents on dose-response curves of 5-hydroxytryptamine-and dopamine-mediated behaviours and 5-HT2 receptor number in frontal cortex, Br. J. Pharmacol. 80: 377–385
Green, A.R., Johson, P., and Nimgaonkar, V.L., 1983b, Increased 5-HT receptor number in brain as a probable explanation for the enhanced 5-hydroxytryptamine-mediated behaviour following repeated electroconvulsive shock administration to rats, Br. J. Pharmacol. 80: 173–177
Green, A.R., Guy, A.P., and Gardner, C.R., 1984a, The behavioural effects of RU 24969, a suggested 5-HTI agonist in rodents and the effect on the behaviour of treatment with antidepressants, Neuropharmacology 23 655–661
Green, A.R., Nimgaonkar, V.L., and Goodwin, G.M., 1984b, β-Andrenoceptor agonists, ECT and other antidepressants: Effects on serotonin biochemistry and function, in: Proceedings of the 9th International Congress of Pharmacology, Vol. 3 (W.D.M. Paton, J.F. Mitchell, and R. Turner, eds.), Macmillan Press, Basingstoke, England, pp. 117–124
Greenfield, S. A., 1984, Acetylcholinesterase may have novel functions in the brain, Trends Neurosci. 7: 364–368.
Heal, D. J., 1984, Phenylephrine-induced activity in mice as a model of central α1-adrenoceptor function. Effects of acute and repeated administration of antidepressant drugs and electroconvulsive shock, Neuropharmacology 23: 1241–1251.
Heal, D. J., and Green, A. R., 1978, Repeated electroconvulsive shock increases the behavioural responses of rats to injection of both dopamine and dibutyryl cyclic AMP into the nucleus accumbens, Neuropharmacology 17: 1085–1087.
Heal, D. J., Phillips, A. G., and Green, A. R., 1978, Studies on the locomotor activity produced by injection of dibutyryl cyclic 3′5′-AMP into the nucleus accumbens of rats, Neuropharmacology 17: 265–270.
Heal, D. J., Akagi, H., Bowdler, J. M., and Green, A. R., 1981, Repeated electroconvulsive shock attenuates clonidine-induced hypoactivity in rodents, Eur. J. Pharmacol 75: 231–237.
Heal, D. J., Lister, S., Smith, S. L., Davies, C. L., Molyneux, S. G., and Green, A. R., 1983, The effects of acute and repeated administration of various antidepressants on clonidine hypoactivity in mice and rats, Neuropharmacology 22: 983–992.
Hendley, E. D., 1976, Electroconvulsive shock and norepinephrine uptake kinetics in rat brain, Psychopharmacol. Commun. 2: 17–25.
Holaday, J. W., and Belenky, G. L., 1980, Opiate-like effects of electroconvulsive shock in rats: A differential effect of naloxone on nociceptive measures, Life Sci. 27: 1929–1938.
Holaday, J. W., Belenky, G. L., Loh, H. H., and Meyerhoff, J. L., 1978, Evidence for endorphin release during electroconvulsive shock, Soc. Neurosci. Abstr. 4: 409.
Hong, J. S., Gillin, J. C., Yang, H-Y. T., and Costa, E., 1979, Repeated electroconvulsive shocks and the brain content of endorphins, Brain Res. 177: 273–278.
Hong, J. S., Kanamatsu, T., Mcginty, J. F., Obie, J., Dyer, R. S., and Mitchell, C. L., 1985, Amygdaloid kindling increases enkephalin-like immunoreactivity but decreases dynorphin A-like immunoreactivity in rat hippocampus, Fed. Proc. 9: 2535–2539.
Janowsky, A., Okada, F., Manier, D. H., Applegate, C. D., Sulser, F., and Steranka, L. R., 1982, Role of serotonergic input in the regulation of the β-adrenergic receptor-coupled adenylate cyclase system, Science (Washington) 218: 900–901.
Johnson, R. W., Reisine, T., Spotnitz, S., Weich, N., Ursillo, R., and Yamamura, H. I., 1980, Effects of desipramine and yohimbine on alpha2- and beta-adrenoceptor sensitivity, Eur. J. Pharmacol 67: 123–127.
Jones, R. S. G., Mondadori, C., and Olpe, H-R., 1985, Neuronal sensitivity to substance P is increased after repeated treatment with tranylcypromine, carbamazepine or oxaprotaline but decreased after repeated electroconvulsive shock, Neuropharmacology 24: 627–633.
Kellar, K. J., 1984, ECS: effects on serotonergic and β-adrenergic receptor binding sites in brain, in: ECT: Basic Mechanisms ( B. Lerer, R. D. Weiner, and R. H. Belmaker, eds.), John Libbey & Co., London, pp. 46–56.
Kellar, K.J., Cascio, C.S., Butler, J.A., and Kurtzke, R.W., 1981a, Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2-receptors in rat brain, Eur. J. Pharmacol. 69: 515–518
Kellar, K.J., Cascio, C.S., Bergstrom, D.A., Butler, J.A., and Iadarola, P., 1981b, Electroconvulsive shock and reserpine: Effects on β-adrenergic receptors in brain, J. Neurochem. 37: 830–836
Keller, H. H., Schaffner, R., and Haefely, W., 1976, Interactions of benzodiazepines with neuroleptics at central dopamine neurones, Naunyn-Schmiedeberg’s Arch. Pharmac. 294: 1–7.
Kety, S. S., Javoy, F., Thierry, A. M., Julou, Z., and Glowinski, J., 1967, A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat, Proc. Natl. Acad. Sci. USA 58: 1249–1254.
Lambourn, J., and Gill, D., 1978, A controlled comparison of simulated and real ECT, Br. J. Psychiatry 133: 514–519
Lebrecht, U., and Nowak, J.Z., 1980a, Effect of single and repeated electroconvulsive shock on serotonergic system in rat brain, II: Behavioural studies, Neuropharmacology 19: 1049–1053
Lebrecht, U., and Nowak, J.Z., 1980a, Effect of single and repeated electroconvulsive shock on serotonergic system in rat brain, II: Behavioural studies, Neuropharmacology 19: 1055–1061
Lerer, B., 1985, Studies on the role of brain cholinergic systems in the therapeutic mechanisms and adverse effects of ECT and lithium, Biol. Psychiatry 20: 20–40.
Lerer, B., Jabotinsky-Rubin, K., Bannet, J., Ebstein, R. P., and Belmaker, R. H., 1982, Electroconvulsive shock prevents dopamine receptor supersensitivity, Eur. J. Pharmacol. 80: 131–134.
Lerer, B., Stanley, M., Demetriou, S., and Geershon, S., 1983, Effect of electroconvulsive shock on [3H]-QNB binding in rat cerebral cortex and hippocampus, J. Neurochem. 41: 1680–1683.
Lerer, B., Stanley, M., Mcintyre, I., and Altman, A., 1984, Electroconvulsive shock and brain muscarinic receptors: Relationship to anterograde amnesia, Life Sci. 35: 2659–2664.
Lewin, E., and Bleck, V., 1981, Electroshock seizures in mice: Effect on brain adenosine and its metabolites, Epilepsia 22: 577–581.
Lighton, K. G., Marsden, C. A., Bennett, G. W., Minchin, M. C. W., and Green, A. R., 1984, Decrease in levels of thyrotropin-releasing hormone (TRH) in the n. accumbens and lumbar spinal cord following repeated electroconvulsive shock, Neuropharmacology 23: 963–966.
Lighton, C., Bennett, G. W., and Marsden, C. A., 1985, Increase in levels and ex vivo release of thyrotrophin-releasing hormone (TRH) in specific regions of the CNS of the rat by chronic treatment with antidepressants, Neuropharmacology 24: 401–406.
Lloyd, K. G., and Pilc, A., 1984, Chronic antidepressants and GABA-B receptors, Poster; 9th International Congress on Pharmacology, London.
Lloyd, K. G., Morselli, P. L., Depoortere, H., Fournier, V., Zivcovic, B., Scatton, B., Broekkamp, C., Worms, P., and Bartholini, G., 1983, The potential use of GABA agonists in psychiatric disorders, evidence from studies with progabide on animal models and clinical trials, Pharmacol. Biochem. Behav. 18: 957–966.
Lloyd, K. G., Thuret, F., and Pilc, A., 1985, Upregulation of gamma-aminobutyric acid (GABA)B binding sites in rat frontal cortex: A common action of repeated administration of different classes of antidepressants and electroshock, J. Pharmacol. Exp. Therap. 235: 191–199.
Longoni, R., Mulas, A., Oderfeld, B., Pepeu, I. M., and Pepeu, G., 1976, Effect of single and repeated electroshock applications on brain acetylcholine levels and choline acetyl transferase activity in the rat, Neuropharmacology 15: 283–286.
Masserano, J. M., Takimoto, G. S., and Weiner, N., 1981, Electroconvulsive shock increases tyrosine hydroxylase activity in the brain and adrenal gland of the rat, Science (Washington) 214: 662–665.
Mcgaugh, J. L., 1966, Time-dependent processes in memory storage, Science (Washington) 153: 1351–1358.
Mcnamara, J. O., Peper, A. M., and Patrone, V., 1980, Repeated seizures induce long-term increase in hippocampal benzodiazepine receptors, Proc. Natl. Acad. Sci. USA 77: 3029–3032.
Mcwilliam, J. R., Meldrum, B. S., and Checkley, S. A., 1981, Enhanced growth hormone response to clonidine after repeated electroconvulsive shock in a primate species, Psychoneuroendocrinology 6: 77–79.
Mcwilliam, J. R., Meldrum, B. S., and Checkley, S. A., 1982, Changes in noradrenergic neuroendocrine responses following repeated seizures and the mechanisms of action of ECT, Psychopharmacology 77: 53–57.
Mellanby, J., Green, A. R., Impey, L., Oates, C., and Traynor, L., 1984, The effect of electroconvulsive shock on learning and memory in rats, Acta Neurol. Scand. 69 (99): 115–118.
Metafora, S., Persico, M., Felsani, A., Ferraiuolo, R., and Guiditta, A., 1977, On the mechanism of the electroshock-induced inhibition of protein synthesis in rabbit cerebral cortex, J. Neurochem. 28: 1335–1346.
Metz, A., Goodwin, G. M., and Green, A. R., 1985, The administration of baclofen to mice increases 5-HT2-mediated head-twitch behaviour and 5-HT2 receptor number in frontal cortex, Neuropharmacology 24: 257–260.
Minchin, M. C. W., and Nutt, D. J., 1983, Studies on [3H]-diazepam and [3H]-ethyl-β-carboline carboxylate binding to rat brain in vivo. I: Regional variations in displacement, J. Neurochem. 41: 1507–1512.
Minchin, M. C. W., and Nutt, D. J., 1984, The effect of repeated electroconvulsive shock on the function of THIP, a GABA agonist, Pharmacol. Biochem. Behav. 21: 491–493.
Minchin, M. C. W., Williams, J., Bowdler, J. M., and Green, A. R., 1983, The effect of electroconvulsive shock on the uptake and release of noradrenaline and 5-hydroxy- tryptamine in rat brain slices, J. Neurochem, 40: 765–768.
Modigh, K., 1975, Electroconvulsive shock and postsynaptic catecholamine effects: Increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS, J. Neural Transm. 36: 19–32.
Modigh, K., 1976, Long-term effects of electroconvulsive shock therapy on synthesis, turnover, and uptake of brain monoamines, Psychopharmacology 49: 179–185
Modigh, K., 1979, Long lasting effects of ECT on monoaminergic mechanisms, in: Neuropsychopharmacology ( B. Saletu, P. Berner, and L. Hollister, eds.), Pergamon Press, Oxford.
Musacchio, J. M., Julou, I., Kety, S. S., and Glowinski, J., 1969, Increase in rat brain tyrosine hydroxylase activity produced by electroconvulsive shock, Proc. Natl. Acad. Sci. USA 63: 1117–1119.
Myslobodsy, M. S., and Mintz, M., 1981, Postictal behavioral arrest in the rat: “Catalepsy” or “catatonia”? Life Sci. 28: 2287–2293.
Myslobodsky, M., Kofman, O., and Mintz, M., 1981, Convulsant-specific architecture of the postictal behaviour syndrome in the rat, Epilepsia 22: 559–568.
Newman, M., Zohar, J., Kalian, M., and Belmaker, R. H., 1984, Effects of ECS on adenosine receptor systems in the brain, in: ECT: Basic Mechanisms ( B. Lerer, R. D. Weiner, and R. H. Belmaker, eds.), John Libbey Co., London, pp. 57–61.
Nimgaonkar, V. L., Goodwin, G. M., Davies, C. L., and Green, A. R., 1985, Down-regulation of β-adrenoceptors in rat cortex by repeated administration of desipramine, electroconvulsive shock and clenbuterol requires 5-HT neurones but not 5-HT, Neuropharmacology 24: 279–283.
Nimgaonkar, V. L., Heal, D. J., Davies, C. L., and Green, A. R., 1986, Studies on rat brain catecholamine synthesis and B-adrenoceptor number following administration of electroconvulsive shock, desipramine and clenbuterol, J. Neurol. Transm. 65: 245–259.
Nutt, D. J., and Minchin, M. C. W., 1983, Studies of [3H]-diazepam and [3H]-ethyl-β-carboline carboxylate binding to rate brain in vivo. II: Effects of electroconvulsive shock, J. Neurochem. 41: 1514–1517.
Nutt, D.J., Green, A.R., and Grahame-Smith, D.G., 1980a, Enhanced 5-hydroxytryptamine- and dopamine-mediated behavioural responses following convulsions. 1: The effects of single and repeated bicuculline-induced seizures, Neuropharmacology 19: 897–900
Nutt, D.J., Cowen, P.J., and Green, A.R., 1980b, On the measurement of rats of the convulsant effect of drugs and the changes which follow electroconvulsive shock, Neuropharmacology 19: 1018–1023
Nutt, D. J., Cowen, P. J., and Green, A. R., 1981, Studies on the post-ictal rise in seizure threshold, Eur. J. Pharmacol. 71: 287–295.
Nutt, D. J., Smith, S. L., and Heal, D. J., 1982, Hypophysectomy does not prevent the enhanced monoamine-mediated behavioural responses following repeated electroconvulsive shocks, Neuropharmacology 21: 881–884.
Olney, J. W., De Gubaneff, T., and Labruyere, J., 1983, Seizure-related brain damage induced by cholinergic agents, Nature 310: 520–522.
Pandey, G. N., Heinze, W. J., Brown, B. D., and Davis, J. M., 1979, Electroconvulsive shock treatment decreases beta-adrenergic receptor sensitivity in rat brain, Nature 280: 234–235.
Paul, S. M., and Skolnick, P., 1978, Rapid changes in brain benzodiazepine receptors after experimental seizures, Science 202: 892–894.
Pedigo, N. W., Yamamura, H. I., and Nelson, D. L., 1981, Discrimination of multiple [3H]-5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain, J. Neurochem. 36: 220–226.
Peroutka, S. J., and Snyder, S. H., 1979, Multiple serotonin receptors: Differential binding of [3H]-hydroxytryptamine, [3H]-lysergic acid diethylamide and [3H]-spiroperidol, Mol. Pharmacol. 16: 687–699.
Peroutka, S. J., and Snyder, S. H., 1980, Long term antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding, Science 210: 88.
Perumal, A.S., and Barkai, A.I., 1982, β-Adrenergic receptor binding in different regions of rat brain after various intensities of electroshock: Relationship to postictal EEG, J. Neurosci. Res. 7: 289–296
Pilc, A., and Vetulani, J., 1982, Depression by chronic electroconvulsive treatment of clonidine hypothermia and [3H]-clonidine binding to rat cortical membranes, Eur. J. Pharmacol. 80: 109–113.
Pilc, A., Rogoz, Z., and Byrska, B., 1980, Some central effects of impromidine, a potent agonist of histamine H2 receptor, Neuropharmacology 19: 947–950.
Royal College of Psychiatrists, 1977, The Royal College of Psychiatrists memorandum on the use of electroconvulsive therapy, Br. J. Psychiatry 131: 261–272.
Sackheim, H. A., Decina, P., Prohovnik, I., Malitz, S., and Resor, S. K., 1983, Anticonvulsant and antidepressant properties of electroconvulsive therapy: A proposed mechanism of action, Biol. Psychiatry 18: 1301–1310.
Sattin, A., 1971, Increase in the content of adenosine 3′5′-monophosphate in mouse forebrain during seizures and prevention of the increase by methylxanthines, J. Neurochem. 18: 1087–1096
Sattin, A., 1981, Adenosine as a mediator of antidepressant treatment, in: Chemisms of the Brain ( R. Rodnight, H. S. Bachelard, and W. L. Stahl, eds.), Churchill-Livingstone, Edinburgh, pp. 265–275.
Schlicker, E., Classen, K., and Gothert, M., 1984, GABA receptor-mediated inhibition of serotonin release in the rat brain, Naunyn-Schiedeberg’s Arch. Pharmac. 326: 99–105.
Serra, G., Argiolas, A., Fadda, F., Melis, M. R., and Gessa, G. L., 1981, Repeated electroconvulsive shock prevents the sedative effect of small doses of apomorphine, Psychopharmacology 73: 194–196.
Shields, P. J., 1972, Effects of electroconvulsive shock on the metabolism of 5-HT in the rat brain, J. Pharm. Pharmacol. 23: 919–920.
Slade, A. P., and Checkley, S. A., 1980, A neuroendocrine study of the mechanism of action of ECT, Br. J. Psychiatry 137: 217–221.
Stanford, S. C., and Nutt, D. J., 1982, Comparison of the effects of repeated electroconvulsive shock on α2-adrenoceptors different regions of rat brain, Neuroscience 7: 1753–1757.
Stanford, C., Nutt, D. J., and Cowen, P. J., 1983, Comparison of the effects of chronic desmethylimipramine administration on α2- and β-adrenoceptors in different regions of rat brain, Neuroscience 8: 161–164.
Stanley, M., and Lerer, B., 1985, Electroconvulsive shock and cholinergic function: Role of striatal muscarinic receptors, Convulsive Ther. 1: 158–166.
Steiner, J. A., and Grahame-Smith, D. G., 1980, The effect of repeated electroconvulsive shock on corticosterone responses to centrally acting pharmacological stimuli in the male rate, Psychopharmacology 71: 205–212.
Steiner, J. A., Evans, G., and Grahame-Smith, D. G., 1982, The effect of repeated electroconvulsive shocks on growth hormone secretion and growth hormone responses to clonidine in the intact rat, Psychopharmacology 76: 98–100.
Sugrue, M. F., 1981, Effects of acutely and chronically administered antidepressants on the clonidine-induced decrease in rat brain 3-methoxy-4-hydroxyphenylethyleneglycol sulphate content, Life Sci. 28: 377–384.
Sugrue, M. F., 1982, A study of the sensitivity of rat brain α2-adrenoceptors during chronic antidepressant treatments, Naunyn-Schmiedeberg’s Arch. Pharmacol. 320: 90–96.
Sulser, F., and Mobley, P. L., 1981, Regulation of central noradrenergic receptor functions: New vistas on the mode of action of antidepressant treatments, in: Neuroregulators: Basic and Clinical Aspects ( E. Usdin, J. M. Davis, and W. E. Bunney, eds.), John Wiley & Sons, Chichester, pp. 55–83.
Tacke, U., Paananen, A., and Tuomisto, J., 1984, Seizure thresholds and their postictal changes in audiogenic seizure (AGS)-susceptible rats, Eur. J. Pharmacol. 104: 85–92.
Tortella, F. C., Cowan, A., Belenky, G. L., and Holaday, J. W., 1981, Opiate-like electroencephalographic and behavioural effects of electroconvulsive shock in rats, Eur. J. Pharmacol. 76: 121–128.
Tortella, F. C., Cowan, A., and Adler, M. W., 1984, Studies on the excitatory and inhiitory influence of intracerebroventricularly injected opioids on seizure thresholds in rats, Neuropharmacology 23: 749–754.
Turski, W. A., Czuczwar, S. J., Kleinvok, Z., and Turski, L., 1983, Cholinomimetics produce seizures and brain damage in rats, Experientia 39: 1408.
U’prichard, D., Bechtel, W., Roust, B., and Snyder, S. H., 1979, Multiple apparent alpha noradrenergic receptor binding sites in rat brain: Effect of 6-hydroxydopamine, Mol. Pharmacol. 16: 47–60.
Vetulani, J., 1984, Changes in responsiveness of central aminergic structures after chronic ECS, in: ECT: Basic Mechanisms ( B. Lerer, R. D. Weiner, and R. H. Belmaker, eds.), John Libbey Co., London, pp. 33–45.
Vetulani, J., and Pilc, A., 1982, Postdecapitation convulsions in the rat measured with an Anime motility meter: Relation to central α-adrenoceptors, Eur. J. Pharmacol. 85: 269–275.
Vetulani, J., and Sulser, F., 1975, Action of various antidepressant treatments reduced reactivity of noradrenergic cyclic AMP generating system in limbic forebrain, Nature 257: 495–496.
Vetulani, J., Stawarz, R. J., Dingell, J. V., and Sulser, F., 1976, A possible common mechanism of action of antidepressant treatments. Reduction in the sensitivity of noradrenergic cyclic AMP generating system in the rat limbic forebrain, Naunyn-Schmiedeberg’s Arch. Pharmacol. 293: 109–144.
Vetulani, J., Antkiewicz-Michaluk, L., Golembiowska-Nikitin, K., Michaluk, J., Pilc, A., and Rokosz, A., 1980, The effect of multiple imipramine administration on monoaminergic systems of the rat brain, Pol. J. Pharmacol. 32: 523–530.
Vetulani, J., Lebrecht, U., and Pilc, A., 1981, Enhancement of responsiveness of the central serotonergic system and serotonin-2-receptor density in rat frontal cortex by electroconvulsive treatments, Eur. J. Pharmacol. 76: 81–85.
Vetulani, J., Antkiewicz-Michaluk, L., Rokosz-Pelc, A., and Pilc, A., 1983, Chronic electroconvulsive treatment enhances density of [3H]-prazosin binding sites in the central nervous system of the rat, Brain Res. 275: 392–395.
Wasterlain, C. G., and Csiszor, E., 1980, Cyclic nucleotide metabolism in mouse brain during seizures induced by bicuculline or dibutyryl cyclic guanosine monophosphate, Exp. Neurol. 70: 260–268.
Weeks, D., Freeman, C. P. L., and Kendell, R. E., 1980, ECT III: Enduring cognitive defects, Br. J. Psychiatry 137: 26–37.
Weilosz, M., 1981, Increased sensitivity to dopaminergic agonists after repeated electroconvulsive shock in rats, Neuropharmacology 20: 941–945.
White, D. K., and Barrett, R. J., 1981, The effects of electroconvulsive shock on the discriminative stimulus properties of d-amphetamine and apomorphine: Evidence for dopamine receptor alteration subsequent to ECS, Psychopharmacology 73: 211–214.
Worms, P., and Lloyd, K. G., 1978, Influence of GABA-agonists and antagonists on neuroleptic-induced catalepsy in rats, Life Sci. 23: 475–478.
Yoshikawa, K., Hong, J. S., and Sabol, S. L. 1985, Electroconvulsive shock increases pre-proenkephalin messenger RNA abundance in rat hypothalamus, Proc. Natl. Acad. Sci. U.S.A. 82: 589–593.
Zivkovic, B., Scatton, B., Dedek, J., and Bartholini, G., 1982, GABA influence on noradrenergic and serotonergic transmissions: Implications in mood regulation, in: New Vistas in Depression, Advances in Bioscience, Vol. 40, Pergamon Press, Oxford, pp. 195–201.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Green, A.R., Nutt, D.J. (1987). Psychopharmacology of Repeated Seizures: Possible Relevance to the Mechanism of Action of Electroconvulsive Therapy. In: Iversen, L.L., Iversen, S.D., Snyder, S.H. (eds) Handbook of Psychopharmacology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1819-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1819-4_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9017-9
Online ISBN: 978-1-4613-1819-4
eBook Packages: Springer Book Archive